Home  |  About JAPTR |  Editorial board  |  Search |  Ahead of print  |  Current issue  |  Archives |  Submit article  |  Instructions  |  Subscribe  |  Advertise  |  Contacts  |Login 
Users Online: 341   Home Print this page Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


Pharmacogenetics: The future medicine

Saini Rajiv, Saini Santosh, Sugandha R S

Year : 2010| Volume: 1| Issue : 4 | Page no: 423-424

   This article has been cited by
1 Integration of pharmacogenomics and theranostics with nanotechnology as quality by design (QbD) approach for formulation development of novel dosage forms for effective drug therapy
Vikas Jhawat,Monika Gulia,Sumeet Gupta,Balaji Maddiboyina,Rohit Dutt
Journal of Controlled Release. 2020; 327: 500
[Pubmed]  [Google Scholar] [DOI]
2 Carbamazepine adverse drug reactions
Ingrid Fricke-Galindo,Adrián LLerena,Helgi Jung-Cook,Marisol López-López
Expert Review of Clinical Pharmacology. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
3 Genetic polymorphisms associated with circadian rhythm dysregulation provide new perspectives on bipolar disorder
Thomaz Oliveira,Victor Marinho,Valécia Carvalho,Francisco Magalhăes,Kaline Rocha,Carla Ayres,Silmar Teixeira,Monara Nunes,Victor Hugo Bastos,Giovanny R Pinto
Bipolar Disorders. 2018;
[Pubmed]  [Google Scholar] [DOI]
4 The role of cytochrome P450 pharmacogenomics in chronic non-cancer pain patients
Tatiana Tverdohleb,Bora Dinc,Ivana Knezevic,Kenneth D. Candido,Nebojsa Nick Knezevic
Expert Opinion on Drug Metabolism & Toxicology. 2016; : 1
[Pubmed]  [Google Scholar] [DOI]


Read this article